Skip to content

Research on Integrated Community Management of Type 2 diabetes Alleviation Based on Intestinal Microflora Regulation and Its Application

Research on Integrated Community Management of Type 2 diabetes Alleviation Based on Intestinal Microflora Regulation and Its Application

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077276
Enrollment
Unknown
Registered
2023-11-02
Start date
2023-11-06
Completion date
Unknown
Last updated
2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Interventions

Comprehensive Management Group:Intestinal microbiota regulation,continuous glucose monitoring and conventional scientific management measures
General Management Group:Conventional scientific management measures
continuous glucose monitoring group:continuous glucose monitoring and conventional scientific management measures

Sponsors

The Fifth Affiliated Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.patients older than 35 years old, less than 65 years of age, male and female;2.Conform to the diagnostic criteria for type 2 diabetes in the Chinese Guidelines for the Prevention and Treatment of Type 2 diabetes (2020);3.Currently using glucose-lowering medications;4.Compliance therapy, the patient and family members, voluntarily accept this study, and sign the participants informed consent.

Exclusion criteria

Exclusion criteria: 1.HbA1c=12%;2.Acute complications associated with diabetes within 3 months;3.Acute cerebrovascular accident and/or acute myocardial infarction within 6 months;4.Poor compliance and physical condition that cannot cooperate with or tolerate interventions in this study,such as mental illness,cancer,severe organ dysfunction,paralysis,severe gastrointestinal disease,et al;5.Pregnant and lactating women;6.Other situations that are not suitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
Diabetes remission rate;

Secondary

MeasureTime frame
Macrogenomic analysis of intestinal microflora;Metabolomic analysis of intestinal microflora;HOMA-IR;C-peptide level;blood glucose level;HbA1c;TNF-a;IL-6;IL-10;HOMA-IS;HOMA-ß;BMI;Blood lipid level;TIR;CV;

Countries

China

Contacts

Public ContactYin Kai

The Fifth Affiliated Hospital of Southern Medical University

kaiyinby@qq.com+86 177 7628 5153

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026